Skip to main content

Full coverage

What to know about ibogaine, the drug Presley Gerber used for treatment months before death

2 sources|Diversity: 63%Left blind spot|

By Extra Extra Editorial

Cross-spectrum analysis, synthesized with AI from 2 sources · Updated

How we analyze coverage

Presley Gerber, son of supermodel Cindy Crawford, was found dead in a rehab facility bedroom months after undergoing treatment with ibogaine, a psychoactive substance derived from an African plant. Ibogaine is used in some addiction treatment programs despite remaining illegal in the United States, though it has shown promise in clinical research for opioid dependence. The coverage examines both the drug's therapeutic potential and the circumstances surrounding Gerber's death at the facility.

Center· 1 sources

USA Today frames the story as an educational explainer about ibogaine itself—what the substance is, how it works, and its clinical status—while contextualizing it through Gerber's treatment history. The outlet balances discussion of the drug's potential benefits against safety concerns and regulatory gaps.

Right· 1 sources

The New York Post emphasizes the immediate, concrete detail of where Gerber was found, leading with the physical circumstances of his death at the rehab facility. This framing prioritizes the incident itself over broader context about the treatment method.

Key Differences

  • Center coverage focuses on explaining ibogaine as a substance and treatment modality, while right-leaning coverage leads with the specific location and circumstances of death.
  • Left-leaning outlets provide no coverage of this story, creating a notable absence of progressive media engagement with either the addiction treatment angle or the celebrity death narrative.

How this story is being covered

2 reports from 2 outlets63/100 cross-spectrum diversityNo left-leaning coverage yet1 high-reliability source

Extra Extra has grouped 2 reports on this story from 2 news outlets across the political spectrum. By political lean, that breaks down as 1 center and 1 right-leaning sources.

Its coverage-diversity score of 63 out of 100 means the story is being reported across multiple parts of the spectrum, though the volume leans toward one side. Notably, no left-leaning outlet in our index has picked the story up yet — a left-side blind spot that often signals a topic resonating more with conservative audiences.

On reliability, 1 of the 2 rated outlets carry a high or mostly-factual reliability rating (A or B) and 1 outlet fall into our mixed or lower-reliability tier (C or D). Ratings are drawn from independent assessments and are meant to help you weigh each report, not to tell you which to trust.

Coverage of this story has developed over roughly 13 hours, so the perspectives below capture how the framing shifted as the story matured.

Below, the same story is laid out side by side as left, center, and right outlets reported it. Read across the columns and watch what changes: the headline emphasis, which facts lead, the adjectives, and what each side leaves out. The story itself rarely changes — the framing almost always does.

Outlets covering this story: USA Today, NY Post.


Left(0)

No left-leaning sources covered this story

Center(1)

Right(1)

Get this analysis in your inbox

The Daily Spectrum: one email, three perspectives on the day's biggest stories.

Free forever. Unsubscribe anytime. No spam.

New to comparing coverage? Start with our guides to reading the news critically.

Back to Compare